One study qualified for the systematic review.
These results were based on a systematic review of all available studies, conducted on behalf of the Task Force by a team of specialists in systematic review methods, and in research, practice, and policy related to vaccinations to prevent diseases.
There is no information for this section.
This study evaluated the implementation of a $10 incentive to increase hepatitis B vaccination coverage among recruited injection drug users. The incentive increased vaccination by 35 percentage points. Although this is a relatively large increase, this single study alone did not provide enough evidence for the Task Force to determine whether or not client incentives by themselves are effective in increasing vaccination coverage.
An economic review of this intervention was not conducted because the Task Force did not have enough information to determine if the intervention works.
Applicability of this intervention across different settings and populations was not assessed because the Task Force did not have enough information to determine if the intervention works.
No content is available for this section.
No content is available for this section.
to help prevent the spread of COVID-19. Visit www.cdc.gov/coronavirus